跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pedcombi 2 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pedcombi 2
Approved
STANDARD
Pedcombi 2
San Marino Laboratories Corp.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
32c1969d9c2d2aa1
Company
San Marino Laboratories Corp.
Type
Standard
Approval Details
Approval Id
32c1969d9c2d2aa1
Drug Approval Philippines Name
Pedcombi 2
Product Name
Pedcombi 2
Registration Number
DR-XY37814
Brand Name
Pedcombi 2
Generic Name
*Rifampicin (Crisarfam DS) **Isoniazid + Pyridoxine hydrochloride (Nicazid DS)
Dosage Form
Syrup
Dosage Strength
200 mg/5 Ml Suspension 200 mg/20 mg per 5mL
Manufacturer
San Marino Laboratories Corp.
Trader
Pharmacare Products Corporation
Issuance Date
27 November 2020
Expiry Date
16 July 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
32c1969d9c2d2aa1
Type
Standard
Back to Philippines FDA Approvals